Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years, Virus Res, vol.162, pp.80-99, 2011. ,
The pathogenesis of respiratory syncytial virus disease in childhood, Br Med Bull, vol.61, pp.13-28, 2002. ,
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease, Nat Med, vol.15, pp.34-41, 2009. ,
Neutralization Epitopes of the F Glycoprotein of Respiratory Syncytial Virus : Effect of Mutation upon Fusion Function, J Virol, vol.63, pp.2941-2950, 1989. ,
,
, RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine, Nanomedicine, vol.13, issue.2
,
, Mol Biol, vol.409, pp.853-66, 2011.
Proof of principle for epitope-focused vaccine design, Nature, vol.507, pp.201-207, 2014. ,
Advances in RSV vaccine research and development -A global agenda, Vaccine, vol.34, pp.2870-2875, 2016. ,
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies, Vaccine, vol.21, pp.3479-3482, 2003. ,
Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves, J Virol, vol.69, pp.6658-64, 1995. ,
Immunology of bovine respiratory syncytial virus in calves, Mol Immunol, vol.66, pp.48-56, 2015. ,
The nine Cterminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer, J Gen Virol, vol.88, pp.196-206, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00167652
Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus, Science, vol.326, pp.1279-83, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00457523
Sub-Version postprint Comment citer ce document ,
,
, RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine, Nanomedicine, vol.13, issue.2
,
, Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates, Mol Ther -Methods Clin Dev, vol.2, p.15018, 2015.
Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge, J Clin Invest, vol.125, pp.1637-1647, 2015. ,
Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines, J Immunol, vol.182, pp.3718-3745, 2009. ,
Fc receptor but not complement binding is important in antibody protection against HIV, Nature, vol.449, pp.101-105, 2007. ,
Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity, J Immunol, vol.172, pp.5598-605, 2004. ,
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection, J Immunol, vol.186, pp.1022-1053, 2011. ,
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody, Science, vol.340, pp.1113-1117, 2013. ,
, Version postprint Comment citer ce document
,
, RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine, Nanomedicine, vol.13, issue.2